Ros1-rearranged Solid Tumors

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2025-10-24
Clinical Trial Update: A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) [Phase 1, Phase 2]
Phase 1/2 study assessing Zidesamtinib (NVL-520) in patients with ROS1-rearranged non-small cell lung cancer and other ROS1-rearranged solid…